⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr. Stephen P. Dale, M.D., as Chief Medical Officer
globenewswire.com
KURA
AZN
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
businesswire.com
AZN
Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course: Explore Its Vast Potential in Drug and Therapeutic Development (Mar 11th - Mar 12th, 2026)
globenewswire.com
AZN
Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight
prnewswire.com
AZN
JNJ
PFE
ORGN
$18.67 Bn MASH Treatment Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029 & 2034
globenewswire.com
MDGL
NVO
LLY
AZN
Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial
globenewswire.com
AZN
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic Collaborations - ResearchAndMarkets.com
businesswire.com
MRK
BMY
AZN
JNJ
NVS
Regenexx Pain Solution Center Bangladesh Launches Advanced Regenerative Rheumatology Program, Introducing Breakthrough Non-Surgical Pain Relief and Autoimmune Care In Bangladesh & Globally
accessnewswire.com
NVS
PFE
AZN
ABBV
LLY
GSK
AMGN
Debbie's Dream Foundation: Curing Stomach Cancer Thanks Its 2025 Industry Partners for Advancing Critical Programs and Patient Support
prnewswire.com
AMGN
BMY
ARCX
AZN
GILD
JAZZ
LLY
MRK
ASTL
THTX
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
globenewswire.com
HCM
AZN